Back to Search
DEBORAH ELDER, MD
MD
Pediatric Endocrinology Physician
NPI: 1306927454Individual
Specialties, Licenses & Credentials
Pediatric Endocrinology PhysicianPrimary
Pediatrics — Pediatric Endocrinology
Code: 2080P0205X
35079609(OH)
Research & Publications (20)
Abnormalities in glucose tolerance are common in children with fanconi anemia and associated with impaired insulin secretion.
PMID 18454466·Pediatr Blood Cancer·2008
8-other
Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes.
PMID 18035147·J Pediatr·2007
8-other
Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults.
PMID 16263830·J Clin Endocrinol Metab·2006
8-other
MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues.
PMID 19636399·Int J Clin Exp Pathol·2009
8-other
Sudden unexpected infant death and bedsharing: referrals to the Wellington Coroner 1997-2006.
PMID 19680305·N Z Med J·2009
8-other
The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.
PMID 19389934·Am J Pathol·2009
7-preclinical
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations.
PMID 18794803·Oncogene·2009
8-other
Angiomatoid Spitz nevus: a clinicopathological study of six cases and a review of the literature.
PMID 19278435·J Cutan Pathol·2009
6-review
Drug substances presented as sulfonic acid salts: overview of utility, safety and regulation.
PMID 19222899·J Pharm Pharmacol·2009
6-review
Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.
PMID 19578365·Nat Genet·2009
4-observational
Genome-wide association study identifies three loci associated with melanoma risk.
PMID 19578364·Nat Genet·2009
8-other
Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas.
PMID 18790768·Mol Cancer Ther·2008
8-other
A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel.
PMID 18676756·Clin Cancer Res·2008
3-trial
Going for gold, from Beijing to Munich, highlights from the ESC 2008 Congress: BEAUTIFUL, GISSI-HF, and potential new therapies for acute decompensated heart failure.
PMID 19035873·Cardiovasc Ther·2008
8-other
Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API).
PMID 18835674·J Pharm Biomed Anal·2008
8-other
Detection and assessment of co-association in inhalable drug particles using aerosol time-of-flight mass spectrometry.
PMID 19003851·Rapid Commun Mass Spectrom·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3333 BURNET AVENUE, MLC 7012
CINCINNATI, OH 45229 - Phone
- (513) 636-4744
Quick Facts
- NPI
- 1306927454
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile